Motivational Interviewing for Stronger Patient Engagement in Pharmacotherapy

Motivational interviewing has moved well beyond its origins in addiction counselling to become one of the most studied communication frameworks in modern healthcare. In community pharmacies across Melbourne, Brisbane, and Hobart, pharmacists are increasingly drawing on its principles to help people start, stay with, or safely adjust their medicines. At its core, the approach is deceptively simple: rather than telling a person what to do, the pharmacist works alongside them to draw out their own reasons for change.

For Australian pharmacists the timing could hardly be better. The Therapeutic Goods Administration continues to approve more complex medicines, while the Pharmaceutical Benefits Scheme funds an ever-broader range of therapies for diabetes, cardiovascular disease, hepatitis C, opioid dependence, and mental health. Adherence rates for chronic medicines still hover between 50 and 70 per cent in Australian studies, and the gap between prescribing and outcomes remains stubbornly wide. Motivational interviewing offers a way to narrow that gap without lengthening an already pressured dispensary workflow.

This article explores how MI works in practice, which techniques translate most readily into community pharmacy, and how Australian pharmacists can weave these conversations into funded services such as MedsCheck, Diabetes MedsCheck, and Home Medicines Reviews. It also considers cultural responsiveness, training pathways, and what the evidence says about measurable patient outcomes.

Foundations of Motivational Interviewing in Pharmacy Practice

Motivational interviewing rests on four guiding principles often summarised by PACE: partnership, acceptance, compassion, and evocation. Partnership recognises that the patient is the expert on their own life, while acceptance honours their autonomy and experience. Compassion keeps the pharmacist focused on the patient's wellbeing rather than the pursuit of a clinical target, and evocation draws out motivations, values, and reasons for considering change. These ideas align comfortably with the patient-centred care standards expected of pharmacists registered with AHPRA.

One of the first concepts pharmacists encounter when learning MI is the "righting reflex", the well-meaning impulse to fix the patient's problem or push them towards adherence. In a busy Sydney or Perth pharmacy, that reflex often shows up in statements such as "You really need to take this every day". Motivational interviewing does not forbid such statements entirely, but it asks the pharmacist to first understand the patient's perspective, because advice delivered without engagement rarely changes behaviour.

The practical toolkit behind MI is usually condensed into OARS: open-ended questions, affirmations, reflective listening, and summaries. Open questions invite patients to share their experience rather than deliver a yes-or-no answer. Affirmations recognise effort and strengths the patient may not see themselves. Reflections demonstrate that the pharmacist is listening and gently probe for the patient's underlying meaning. Summaries pull threads together, helping the patient hear their own motivations reflected back. Together, these behaviours create the conditions for "change talk", where patients themselves articulate the reasons they want to do things differently.

The Pharmacist-Patient Conversation: Building Rapport and Trust

A typical Australian community pharmacy consultation may last only three to seven minutes, but the quality of the conversation matters far more than its length. Research shows that patients who feel heard are more likely to disclose concerns about side effects, cost, or stigma, and to agree on a workable plan. Establishing rapport sits at the front of every motivational interviewing exchange, whether the pharmacist is handing over a Webster-pak in Adelaide or reviewing an asthma preventer in Darwin.

Pharmacists already have several funded touchpoints where MI can be deployed. A MedsCheck or Diabetes MedsCheck provides around 30 minutes of structured conversation, while a Home Medicines Review conducted in partnership with a GP offers an even longer window. Even shorter interactions benefit from MI-consistent language. Asking "What would make it easier to take this twice a day?" produces a very different answer than "Are you taking this twice a day?". The first invites collaboration; the second invites defensiveness.

Cultural safety adds another layer. Pharmacists working alongside Aboriginal Health Practitioners follow cultural safety frameworks that align with the spirit of MI. For patients from culturally and linguistically diverse backgrounds, professional interpreters, plain-language summaries, and TGA-approved visual medicine information support shared decision making. In every case, the pharmacist's posture of genuine curiosity tends to outperform lecturing, particularly when the discussion touches on sensitive issues such as mental health or opioid dependence.

Applying MI Techniques Across Common Pharmacotherapy Scenarios

Consider a patient with type 2 diabetes picking up metformin and empagliflozin in suburban Geelong. Instead of launching into a list of instructions, the pharmacist might ask, "On a typical day, where does this medicine fit into your routine?" The patient's answer reveals whether adherence barriers are practical, financial, or emotional. A simple reflection such as "So mornings are already pretty full" validates the patient's reality before problem solving begins.

The same approach adapts well to mental health. Australians prescribed selective serotonin reuptake inhibitors, antipsychotics, or mood stabilisers often feel ambivalent about long-term therapy. Reflective listening helps the pharmacist acknowledge concerns about weight gain, sexual side effects, or sedation rather than dismiss them. When a pharmacist explores the patient's own goals, such as returning to work or reconnecting with family, change talk frequently emerges without the pharmacist having to insist.

In cardiovascular care, simple reflections and scaling questions such as "On a scale of 0 to 10, how confident are you that you can take this every day?" allow patients to surface hidden obstacles such as cost, polypharmacy, or fear of side effects. The pharmacist can then offer information in small, digestible amounts and check what the patient has heard, rather than assuming comprehension. Opioid pharmacotherapy is another area where motivational interviewing has a strong evidence base, and pharmacists supplying methadone, buprenorphine, or long-acting injectable buprenorphine under the relevant state and territory authorities meet patients who may be ambivalent about tapering, about injecting safely, or about accepting take-home naloxone. Drawing on brief MI strategies frames naloxone as a safety net for the whole community rather than as a marker of failure. For readers wanting a closer look at how community pharmacies can support patients with opioid use disorder, this detailed guide walks through real-world workflows and case examples.

Training, Workflow, and Reimbursement Pathways for Australian Pharmacists

The professional services stream within the Seventh Community Pharmacy Agreement supports MedsCheck, Diabetes MedsCheck, Home Medicines Review, and Residential Medication Management Review services that lend themselves naturally to motivational interviewing. These funded consultations already create the time, privacy, and remuneration that allow pharmacists to move beyond transactional supply. For MI to thrive, however, training and workflow design matter as much as funding.

Several Australian providers offer MI workshops tailored to pharmacists, including programmes accredited by the Pharmaceutical Society of Australia and shorter online modules through the Pharmacy Guild of Australia. Workforce research suggests that pharmacists benefit most from blended learning, combining a foundational workshop with peer practice, audio recording of consultations with patient consent, and structured feedback. Skills such as complex reflection, rolling with resistance, and eliciting change talk require rehearsal before they feel natural in front of a queue of waiting customers.

Workflow tweaks also help. Brief prompts embedded into dispensing software, visual cues at the counselling bench, and protected appointment slots during peak times increase the likelihood that MI becomes part of routine practice rather than a one-off event. Pharmacists who have built these habits report that consultations do not necessarily grow longer; they simply become more focused, with less time spent repeating instructions the patient has already mentally discarded.

Cultural Responsiveness, Equity, and the Wider Australian Context

Australia is one of the most culturally and geographically diverse countries in which pharmacists practise, and motivational interviewing offers tools that travel well across those differences. In remote Western Australia and the Northern Territory, pharmacists frequently care for patients whose nearest GP is hundreds of kilometres away. Aboriginal Health Practitioners, community liaison officers, and pharmacists together deliver Closing the Gap PBS measures, including reduced co-payments for eligible patients. An MI-consistent conversation respects the patient's expertise in their own community and avoids assumptions about what good adherence looks like in a different cultural context.

In major metropolitan centres, the challenge is often one of linguistic and health-literacy diversity. Pharmacists serving large Mandarin, Vietnamese, Arabic, or Greek communities can combine MI with TGA-approved Consumer Medicine Information, pictorial dose reminders, and translated resources. The reflective listening skills of MI help the pharmacist confirm understanding rather than assume it. For patients managing polypharmacy across five or more medicines, this confirmation step can prevent dangerous misunderstandings.

Mental health stigma adds another reason to embrace MI. Australians often delay help-seeking for depression, anxiety, and substance use concerns. A pharmacist trained in MI is well placed to recognise cues, offer brief supportive responses, and refer to services such as Headspace for young people, Beyond Blue for adults, or the Suicide Call Back Service, with the same conversation able to include a medicine-related discussion without forcing the patient to choose between emotional support and clinical advice.

Measuring Impact: Outcomes That Matter for Patients and Pharmacies

Pharmacists often ask how to demonstrate the value of motivational interviewing to practice owners, professional organisations, and funders. The honest answer is that outcomes vary by setting, but a handful of measures consistently appear in Australian and international literature. These include self-reported adherence scales, the Morisky Medication Adherence Scale, prescription refill records captured through pharmacy software, glycated haemoglobin for diabetes, blood pressure control, and validated patient-reported outcome measures such as the EQ-5D.

Dimension	Traditional advice-giving	MI-consistent approach
Stance of the pharmacist	Expert directing the patient	Partner collaborating with the patient
Typical opening question	"Are you taking your medicine correctly?"	"What has taking this medicine been like for you?"
Response to resistance	Repeats information or argues	Reflects concern, rolls with resistance
Information delivery	Large block at the start	Elicit-provide-elicit in small chunks
Patient role	Passive recipient	Active contributor to the plan
Evidence on adherence	Modest, often short-lived	Improved across chronic conditions
Fit with funded services	Possible but limited	Strong fit with MedsCheck, HMR, RMMR
Documentation	Adherence status noted	Change talk, plan, confidence and importance rated

Beyond quantitative metrics, pharmacists frequently describe softer shifts: patients return with their own questions, agree to review medicines they had previously refused, and report feeling respected rather than judged. These changes ripple outwards, strengthening the therapeutic relationship and the pharmacy's reputation within the local community.

If you are a pharmacist working in Australia and would like to bring motivational interviewing into your daily practice, start small. Choose one funded consultation each week where you consciously trade one closed question for an open one, and one piece of advice for a reflection. Listen for the patient's own reasons, write them down, and revisit them next time you see the person. Share what you notice with a colleague, and consider joining a local MI practice group or reaching out to Johnathan Laird for further reading and resources. Over time, those small conversational shifts add up to medicines that work better, patients who feel heard, and a profession that continues to grow its value in the Australian health system.